Cidara Therapeutics (CDTX) Misses Q4 EPS by 537c

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($5.37).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
• Macquarie Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Neutral